Patient‐reported outcomes in the Translational Breast Cancer Research Consortium
Year: 2019
Type: article
Abstract: Members of the Translational Breast Cancer Research Consortium conducted an expert-driven literature review to identify a list of domains and to evaluate potential measures of these domains for inclusion in a list of preferred measures. Measures were included if they were easily available, free of charge, and had acceptable psychometrics based on published peer-reviewed analyses. A total of 22 domains and 52 measures were identified during the selection process. Taken together, these measures form a reliable and validated list of measurement tools that are easily available and used in multiple cancer trials to assess patient-reported outcomes in relevant patients.
Source: Cancer
DOI: 10.1002/cncr.32615
Institutions: University of Washington, The University of Texas MD Anderson Cancer Center, Duke University, Duke Cancer Institute, Dana-Farber Cancer Institute, Dana-Farber Brigham Cancer Center, Johns Hopkins University, Sidney Kimmel Comprehensive Cancer Center, University of Alabama at Birmingham, Mayo Clinic, Mayo Clinic Comprehensive Cancer Center (Minnesota), University of California, San Francisco, Indiana University Indianapolis, Indiana University School of Medicine
Language: English
Topic: Cancer survivorship and care
Subfield: Oncology
Field: Medicine
Domain: Health Sciences
Open Access status: green
OpenAlex ID: W2989884353